A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults

Katherine V. Williams, Bo Zhai, John F. Alcorn, Mary Patricia Nowalk, Min Z. Levine, Sara S. Kim, Brendan Flannery, Krissy Moehling Geffel, Amanda Jaber Merranko, Jennifer P. Nagg, Mark Collins, Michael Susick, Karen S. Clarke, Richard K. Zimmerman, Judith M. Martin
doi: https://doi.org/10.1101/2021.09.02.21263043

Article usage

Article usage: September 2021 to November 2024

AbstractFullPdf
Sep 20216976162
Oct 20211371511
Nov 202156413
Dec 20214523
Jan 2022271819
Feb 20223820828
Mar 202238132
Apr 20222845
May 202224513
Jun 20222145
Jul 20221201
Aug 20221963
Sep 20223019
Oct 20224237
Nov 20221922
Dec 20221704
Jan 20231305
Feb 20231725
Mar 2023800
Apr 20232012
May 2023915
Jun 2023961
Jul 20231211
Aug 202314106
Sep 20231442
Oct 2023903
Nov 202325136
Dec 2023806
Jan 202410113
Feb 20241227
Mar 2024624
Apr 20244112
May 2024955
Jun 20241534
Jul 20241819
Aug 20241044
Sep 20242446
Oct 2024843
Nov 2024207
Back to top
Posted September 06, 2021.
Download PDF
Data/Code
Email
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults
Katherine V. Williams, Bo Zhai, John F. Alcorn, Mary Patricia Nowalk, Min Z. Levine, Sara S. Kim, Brendan Flannery, Krissy Moehling Geffel, Amanda Jaber Merranko, Jennifer P. Nagg, Mark Collins, Michael Susick, Karen S. Clarke, Richard K. Zimmerman, Judith M. Martin
medRxiv 2021.09.02.21263043; doi: https://doi.org/10.1101/2021.09.02.21263043
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area